Skip to content

Clinical trials

Terminated Lupus Erythematosus, Systemic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Status: Terminated Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20042
20053
20062
20073
20081
20103
20112
20122
20133
20143
20156
20173
20184
20195
20201
20212
20227
20235
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
National Institute of Allergy and Infectious Diseases (NIAID)5
UCB Pharma3
Amgen2
Genentech, Inc.2
Johns Hopkins University2
Novartis Pharmaceuticals2
Aikaterini Thanou1
Alliance Foundation Trials, LLC.1
Arkansas Heart Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic62
Autoimmune Diseases9
Arthritis, Rheumatoid4
Lupus Nephritis4
Arthritis3
Lupus Erythematosus, Discoid3
Scleroderma, Systemic3
COVID-192
Connective Tissue Diseases2
Fatigue2

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.